BACE2 deficiency impairs expression and function of endothelial nitric oxide synthase in brain endothelial cells
Journal of Neurochemistry · 2023
DOI: 10.1111/jnc.15929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2023. Verfasst von Tongrong He und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Anesthesiology and Perioperative Medicine, and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota…. Hauptthemen laut MEDLINE: Amyloid beta-Protein Precursor, Endothelial Cells. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Mayo Foundation for Medical Education and Research, National Institute on Aging.
Abstract (Originalsprache)
Beta‐site amyloid precursor protein (APP)‐cleaving enzyme 2 (BACE2) is highly expressed in cerebrovascular endothelium. Notably, BACE2 is one of the most downregulated genes in cerebrovascular endothelium derived from patients with Alzheimer's disease. The present study was designed to determine the role of BACE2 in control of expression and function of endothelial nitric oxide synthase (eNOS). Genetic downregulation of BACE2 with small interfering RNA (BACE2siRNA) in human brain microvascular endothelial cells (BMECs) significantly decreased expression of eNOS and elevated levels of eNOS phosphorylated at threonine residue Thr495, thus leading to reduced production of nitric oxide (NO). BACE2siRNA also suppressed expression of APP and decreased production and release of soluble APPα (sAPPα). In contrast, adenovirus‐mediated overexpression of APP increased expression of eNOS. Consistent with these observations, nanomolar concentrations of sAPPα and APP 17mer peptide (derived from sAPPα) augmented eNOS expression. Further analysis established that γ‐aminobutyric acid type B receptor subunit 1 and Krüppel‐like factor 2 may function as downstream molecular targets significantly contributing to BACE2/APP/sAPPα‐induced up‐regulation of eNOS. In agreement with studies on cultured human endothelium, endothelium‐dependent relaxations to acetylcholine and basal production of cyclic GMP were impaired in cerebral arteries of BACE2‐deficient mice. We propose that in the brain blood vessels, BACE2 may function as a vascular protective protein. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Anesthesiology and Perioperative Medicine, and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Tongrong He, Livius V d'Uscio, Zvonimir S Katusic
Förderung
- NIA NIH HHS
- Mayo Foundation for Medical Education and Research
- National Institute on Aging
Zitieren
APA
He, T., d'Uscio, L. V., & Katusic, Z. S. (2023). BACE2 deficiency impairs expression and function of endothelial nitric oxide synthase in brain endothelial cells. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15929
Vancouver
He T, d'Uscio LV, Katusic ZS. BACE2 deficiency impairs expression and function of endothelial nitric oxide synthase in brain endothelial cells. Journal of Neurochemistry. 2023. doi:10.1111/jnc.15929
BibTeX
@article{He2023,
author = {He, Tongrong and d'Uscio, Livius V and Katusic, Zvonimir S},
title = {BACE2 deficiency impairs expression and function of endothelial nitric oxide synthase in brain endothelial cells},
journal = {Journal of Neurochemistry},
year = {2023},
doi = {10.1111/jnc.15929}
}
EUVIMED